Metformin and Myoinositol for PCOS :- Medznat
EN | RU
EN | RU

Help Support

By clicking the "Submit" button, you accept the terms of the User Agreement, including those related to the processing of your personal data. More about data processing in the Policy.
Back

Metformin-Myoinositol targets PCOS symptoms, reduces BMI and insulin levels

PCOS (Polycystic ovary syndrome) PCOS (Polycystic ovary syndrome)
PCOS (Polycystic ovary syndrome) PCOS (Polycystic ovary syndrome)

What's new?

Metformin + Myoinositol presents as a personalized, multifaceted strategy to better manage PCOS and its associated symptoms, improving the quality of life for patients.

According to research published in the ‘African Journal of Biomedical Research’, Metformin, Myoinositol, and their combination may be highly effective for improving the symptoms of polycystic ovarian syndrome (PCOS). This study by A. Samatha et al. conducted between 2019 and 2021, explored the efficacy and safety of these insulin sensitizers in improving biochemical, clinical, and reproductive parameters in PCOS-affected women.

PCOS is a prevalent hormonal condition that impacts ovarian function, thereby causing menstrual anomalies, infertility and obesity. Diagnosed when a woman has more than 20 follicles in at least 1 ovary, it is often associated with increased levels of androgens, insulin resistance, and other metabolic disturbances.

Conducted across two hospitals in Warangal, India, the study involved 710 women and examined the effects of Metformin, Myoinositol, and a combination of the two. After 6 and 12 months, all treatment groups showed noteworthy improvements in fasting insulin levels, prolactin levels, menstrual complaints and body mass index (BMI). Combination therapy outperformed the individual treatments.

The treatment effects were highly significant (p < .001), with moderate effect sizes confirmed by the statistical analysis. Thus, as insulin sensitizers, Metformin, Myoinositol, and Metformin+Myoinositol contribute to improved biochemical, clinical, and reproductive outcomes in women suffering from PCOS.

Source:

African Journal of Biomedical Research

Article:

A Study on Insulin Sensitizers in PCOS Using Anonymous Data

Authors:

A. Samatha et al.

Comments (0)

You want to delete this comment? Please mention comment Invalid Text Content Text Content cannot me more than 1000 Something Went Wrong Cancel Confirm Confirm Delete Hide Replies View Replies View Replies en
Try: